Antihyperlipidemics - Statins: Nursing pharmacology

Last updated: February 23, 2026

Antihyperlipidemics - Statins: Nursing pharmacology

NSG1201

NSG1201

Leg ulcers: Clinical
Venous thromboembolism (VTE): Nursing process (ADPIE)
Wound healing
Peripheral venous disease (PVD): Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Pharmacodynamics: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Vital signs - Pain: Nursing skills
Analgesics: Nursing pharmacology
Antacids: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Antiemetics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antihistamines: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Antirejection immunosuppressants: Nursing pharmacology
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Biologic agents: Nursing pharmacology
Blood products: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Chloramphenicol: Nursing pharmacology
Debridement agents: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Insulin: Nursing pharmacology
Iron preparations: Nursing pharmacology
Keratolytics: Nursing pharmacology
Laxatives: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Lung surfactants and antenatal corticosteroids: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Nitrates: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Oxytocin: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Pharmacokinetics - Distribution: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
Phytonadione (Vitamin K1): Nursing pharmacology
Plant extracts for chemotherapy: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Rho(D) immune globulin: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Tocolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Vaccines: Nursing pharmacology
Pharmacokinetics - Absorption: Nursing pharmacology
Pressure injury: Nursing process (ADPIE)
Emergency care: Falls
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Inflammatory process: Nursing
Nutrition - Oral: Nursing skills
Core measures: Nursing
Standards and methods of documentation: Nursing
Physical assessment - Overview: Nursing
Vital signs - Blood pressure (BP): Nursing skills
Vital signs - Oxygen saturation (SpO2): Nursing skills
Vital signs - Respirations: Nursing skills
Vital signs - Pulse: Nursing skills
Vital Signs - Temperature: Nursing skills
Comprehensive Assessment
Mobility - Ambulation: Nursing skills
Appendicitis: Nursing process (ADPIE)

Notes

ANTIHYPERLIPIDEMICS: STATINS
DRUG NAME
simvastatin (Zocor, FloLipid), rosuvastatin (Crestor), atorvastatin (Lipitor), lovastatin (Altoprev), pravastatin
CLASS
HMG-CoA reductase inhibitors (statins)
MECHANISM OF ACTION
Bind and inhibit HMG-CoA reductase → decrease cholesterol synthesis → decrease cholesterol and LDL levels
INDICATIONS
  • Hypercholesterolemia
  • Increased LDL levels
  • Coronary artery disease
ROUTE(S) OF ADMINISTRATION
  • PO
SIDE EFFECTS
  • Headache, dizziness, insomnia, fatigue
  • Blurred vision, cataracts
  • Abdominal cramps, diarrhea, constipation, flatulence, heartburn, nausea
  • Liver dysfunction
  • Pancreatitis
  • Myalgia, rhabdomyolysis
  • Skin rash
  • Rosuvastatin: renal failure, pancytopenia
CONTRAINDICATIONS AND CAUTIONS
  • Active liver disease
  • Pregnancy
  • Breastfeeding
  • Drug interactions:
    • Cyclosporine, niacin, gemfibrozil, amiodarona, macrolides, antifungals: ↑ risk of rhabdomyolysis
    • Digoxin or warfarin: ↑ levels and toxicity
    • Oral contraceptives: ↑ estrogen levels
    • Protease inhibitors, erythromycin, gemfibrozil, grapefruit: statin toxicity
NURSING CONSIDERATIONS for ANTIHYPERLIPIDEMICS: STATINS
ASSESSMENT AND MONITORING
Assessment
  • Vital signs, cardiovascular status
  • Laboratory test results: CK, hepatic function and lipid panel; with female clients, negative pregnancy test

Monitoring
  • Periodic hepatic function, CK, lipid profile tests
  • Side effects
  • Therapeutic response: decreased LDL and triglyceride levels; improved cardiovascular health
CLIENT EDUCATION
  • Purpose of medication: decrease their LDL and triglyceride levels, decrease risk of coronary artery disease
  • Bedtime administration preferred
  • Avoid grapefruit and grapefruit juice
  • Limit alcohol
  • Female clients of childbearing age: use reliable contraception during treatment; inform healthcare provider if they become pregnant
  • Side effects
    • Gastrointestinal discomfort: eat small, frequent meals
    • Constipation: increase fluid and fiber intake
    • Symptoms to report
      • Rhabdomyolysis: unexplained muscle pain, weakness; brown urine
      • Liver impairment: fatigue, anorexia, nausea, dark urine, or yellowing of eyes or skin
      • Pancreatitis: abdominal pain that occurs after eating, especially pain in the upper abdomen; may radiate to their back
  • Lifestyle modifications
    • Smoking cessation weight control, physical activity, diet high in complex carbohydrates and fiber and low in saturated fat and cholesterol
Author: Victoria S. Recalde, MD
Author: Mary Roberts, MSN, RN
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antihyperlipidemics are medications used to treat clients with increased blood levels of lipids, like cholesterol, by decreasing the levels of low- density lipoproteins or LDLs, which is sometimes referred to as “bad” cholesterol; and to an extent, antihyperlipidemics can also decrease blood triglycerides.

In addition, they’re indicated to treat clients with coronary artery disease and prevent myocardial infarction.

Antihyperlipidemics include different classes of medications, among which some of the most commonly used are HMG-CoA reductase inhibitors, also called statins.

Statins include simvastatin, rosuvastatin, atorvastatin, lovastatin, and pravastatin, which are administered orally.

Once absorbed into the bloodstream, statins travel to the liver, where they inhibit the enzyme HMG-CoA reductase. As a result, there’s a decrease in cholesterol synthesis. This also causes hepatic cells to increase the number of LDL receptors on their surface.

This facilitates the uptake of cholesterol-rich LDLs, and VLDLs to a smaller degree, which provides a moderate decrease in triglyceride level. So ultimately, statins help lower overall lipid levels.

Luckily, statins are very well tolerated. The most common side effects include gastrointestinal symptoms like abdominal cramps, diarrhea or constipation, flatulence, heartburn, and nausea.

Especially with rosuvastatin, clients can develop a skin rash, and may experience headache and dizziness. Other side effects include blurred vision, cataracts, fatigue, and insomnia.

Some of the more serious side effects of statins include myalgia, and rhabdomyolysis, or muscle breakdown.

Next, although rare, statins can cause hepatotoxicity, especially in clients who already have a hepatic disease. Finally, simvastatin and atorvastatin can cause pancreatitis, while rosuvastatin can cause renal failure, and pancytopenia.

As far as contraindications go, statins are teratogenic, so they should be avoided during pregnancy. These medications are also contraindicated during breastfeeding and in clients with active hepatic disease, and should be used with caution in clients with a history of previous hepatic disease.

Regarding interactions, statins are metabolized in the liver by the enzyme cytochrome p450, so clients should avoid taking medications that enhance or inhibit this enzyme’s activity.

Special caution should be taken when combining statins with cyclosporine, niacin, gemfibrozil, amiodarone, macrolides, and antifungal medications, since they can increase the risk of rhabdomyolysis.

In addition, statins can also increase levels of digoxin and warfarin, as well as estrogen when taken with oral contraceptives.

Finally, clients on statins must avoid taking protease inhibitors, erythromycin, or gemfibrozil, as well as consuming grapefruit, as their interaction can increase the levels of statin and result in toxicity.

Okay, if a client with familial hypercholesterolemia is prescribed atorvastatin, start by performing a baseline assessment, including vital signs and cardiovascular status, noting any signs of coronary artery disease, including chest pain or shortness of breath.

Next, review recent laboratory results, specifically CK, hepatic function, and a lipid profile, which includes total cholesterol, triglycerides, HDL, and LDL, levels.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Treatment with Statins in Elderly Patients" Medicina (Kaunas) (2019)
  6. "Effects of statins on mitochondrial pathways" J Cachexia Sarcopenia Muscle (2021)